BioCryst Pharmaceuticals
BCRX
#4646
Rank
ยฃ1.24 B
Marketcap
ยฃ5.97
Share price
2.32%
Change (1 day)
48.63%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total debt

Total debt on the balance sheet as of December 2024 : ยฃ0.62 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total debt is ยฃ0.62 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

BioCryst Pharmaceuticals - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2024-12-31ยฃ0.64 B-0.5%
2023-12-31ยฃ0.64 B5.68%
2022-12-31ยฃ0.61 B39.45%
2021-12-31ยฃ0.43 B114.33%
2020-12-31ยฃ0.20 B217.64%
2019-12-31ยฃ64.55 M32.55%
2018-12-31ยฃ48.7 M20.29%
2017-12-31ยฃ40.48 M-7.01%
2016-12-31ยฃ43.53 M113.8%
2015-12-31ยฃ20.36 M5.69%
2014-12-31ยฃ19.26 M5.95%
2013-12-31ยฃ18.18 M-2.01%
2012-12-31ยฃ18.56 M-3.84%
2011-12-31ยฃ19.3 M
2000-12-31ยฃ0 M
1997-12-31ยฃ0.06 M-65.25%
1996-12-31ยฃ0.17 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
ยฃ0.52 B-16.85%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.03 B 66.07%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.16 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.17 B-71.51%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ20.66 B 3,202.78%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.94 M-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ16.48 B 2,535.69%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ0.51 B-17.93%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ8.57 M-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA